重藥控股(000950.SZ):重慶醫藥(集團)終止競買重鹽集團所持化醫財務公司10%股權
格隆匯5月27日丨重藥控股(000950.SZ)公佈,公司於2019年12月6日召開第七屆董事會第二十八次會議,審議通過了《關於重慶醫藥參與競買重鹽集團所持重慶化醫控股集團財務有限公司10%股權暨關聯交易的議案》。由於此次關聯交易未能獲得中國銀保監會重慶監管局(“重慶銀保監局”)核准,因此重慶醫藥(集團)股份有限公司與重慶市鹽業(集團)有限公司(“重鹽集團”)於2020年5月27日簽訂《合同解除協議書》,終止此次交易。
重藥控股通過控股子公司重慶醫藥(集團)股份有限公司參與公開競買重鹽集團持有的重慶化醫控股集團財務有限公司(“化醫財務公司”)10%股權並簽訂相關協議,然後將該事項報重慶銀保監局審核。因重慶銀保監局最終未核准此次交易,重慶醫藥(集團)股份有限公司與重鹽集團在平等自願的基礎上,經友好協商,一致同意終止此次關聯交易。
重慶醫藥(集團)股份有限公司此次終止競買重鹽集團所持化醫財務公司10%股權,不會對公司生產經營、財務狀況產生不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.